Results 1 to 10 of about 23,637 (175)

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trialResearch in context [PDF]

open access: goldEClinicalMedicine
Summary: Background: Preeclampsia is a hypertensive pregnancy disorder marked by systemic inflammation and endothelial dysfunction. Sulfasalazine, an anti-inflammatory agent, may have therapeutic potential in preeclampsia.
Elif Kadife   +11 more
doaj   +3 more sources

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. [PDF]

open access: goldRedox Biol
Skeie BS   +16 more
europepmc   +2 more sources

Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma. [PDF]

open access: goldMethodsX
Skeie BS   +6 more
europepmc   +2 more sources

Translational Modeling of Gut Microbiome-Mediated Drug Metabolism: A Case Example of Sulfasalazine. [PDF]

open access: goldCPT Pharmacometrics Syst Pharmacol
Cheng L   +8 more
europepmc   +2 more sources

Sulfasalazine prevents lung injury due to intra-abdominal sepsis in rats: possible role of Nrf2 and angiopoietin-2 [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2023
This study aimed to investigate the effect of sulfasalazine in preventing and treating intra-abdominal sepsis-induced acute respiratory distress syndrome (ARDS) in a rat model. Forty male Wistar albino rats were used.
C. Dibekoğlu, Y. Uyanıkgil, O. Erbaş
doaj   +1 more source

Effect of Garlic Oil on Sulfasalazine Induced Injury of Renal Tubules [PDF]

open access: yesThe Egyptian Journal of Histology, 2023
Introduction: Sulfasalazine is a disease modifying anti-rheumatic medication, used in the treatment of idiopathic arthritis. Kidney damage is one of its side effects.Objective: To investigate the protective role of garlic oil against sulfasalazine ...
fouad heikal   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy